|
Market Closed -
Nasdaq
00:00:00 03/10/2026 +04
|
5-day change | 1st Jan Change | ||
| 28.13 USD | +2.59% |
|
+0.18% | - |
| Market Cap | 1.22B 1.08B 1.01B 919M 1.73B 117B 1.75B 12.2B 4.73B 59.74B 4.56B 4.46B 192B | P/E 2026 * |
-8.79x | P/E 2027 * | -9.31x |
|---|---|---|---|---|---|
| Enterprise Value | 1.23B 1.09B 1.02B 931M 1.76B 118B 1.77B 12.36B 4.79B 60.55B 4.63B 4.53B 194B | EV / Sales 2026 * |
-
| EV / Sales 2027 * | - |
| Free-Float |
100% | Yield 2026 * |
-
| Yield 2027 * | - |
NasdaqUSD
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| AVLN | Delayed | |
CBOE
| AVLN | Real-time |
Last Transcript: Avalyn Pharma Inc.
| 1 day | +2.26% | ||
| 1 week | +0.16% | ||
| Current month | -1.28% | ||
| 1 month | -20.95% | ||
| 3 months | -5.40% |
| 1 week | 26.57 | 29 | |
| 1 month | 26.57 | 38.7 | |
| Current year | 24.15 | 40.17 | |
| 1 year | 24.15 | 40.17 | |
| 3 years | 24.15 | 40.17 | |
| 5 years | 24.15 | 40.17 | |
| 10 years | 24.15 | 40.17 |
| Manager | Title | Age | Since |
|---|---|---|---|
Lyn Baranowski
CEO | Chief Executive Officer | 50 | 14/10/2022 |
Douglas Carlson
DFI | Director of Finance/CFO | 47 | 01/05/2024 |
Howard Lazarus
CTO | Chief Tech/Sci/R&D Officer | 60 | 01/08/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
Ketan Patel
BRD | Director/Board Member | 51 | 01/03/2017 |
Tiba Aynechi
BRD | Director/Board Member | 50 | 01/03/2017 |
Lyn Baranowski
BRD | Director/Board Member | 50 | - |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 15/09/26 | Free | Director | 31,182 | 0.0703% | ||
| 01/05/26 | F-Prime, Inc.
| Conversion | Company | -727,585 | 1.4654% | |
| 01/05/26 | SR One Capital Management LP
| Conversion | Company | 38,914,842 | 87.8200% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +2.26% | +0.16% | - | - | 1.22B | ||
| +4.16% | +3.04% | +49.37% | +94.17% | 74.41B | ||
| -3.11% | -3.53% | +21.92% | +74.60% | 59.26B | ||
| +0.89% | -0.63% | +4.28% | +34.51% | 47.14B | ||
| -0.88% | -4.49% | +26.37% | +33.19% | 42.91B | ||
| -0.16% | +0.63% | +351.36% | +688.19% | 44.13B | ||
| -1.39% | -1.99% | +2.47% | +98.14% | 40.79B | ||
| -0.54% | +2.93% | +9.50% | +50.41% | 30.77B | ||
| -2.68% | +5.11% | +33.11% | +19.50% | 29.31B | ||
| +1.72% | -6.71% | -28.06% | +333.27% | 23.71B | ||
| Average | +0.04% | -0.98% | +52.26% | +158.44% | 39.37B | |
| Weighted average by Cap. | +0.05% | -0.41% | +57.36% | +150.03% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | - | - |
| Net income | -124M -111M -103M -94.06M -177M -11.96B -179M -1.25B -484M -6.12B -467M -457M -19.63B | -135M -120M -112M -102M -193M -13.02B -195M -1.36B -527M -6.66B -509M -498M -21.37B |
| Net Debt | 16.4M 14.57M 13.6M 12.39M 23.37M 1.58B 23.59M 165M 63.76M 806M 61.56M 60.22M 2.59B | -442M -393M -367M -334M -631M -42.53B -637M -4.44B -1.72B -21.74B -1.66B -1.62B -69.78B |
Employees
55
| Date | Price | Change | Volume |
|---|---|---|---|
| 03/10/26 | $28.13 | +2.59% | 526,198 |
| 01/10/26 | $27.42 | -3.76% | 423,592 |
| 30/09/26 | $28.49 | +5.13% | 347,615 |
| 29/09/26 | $27.10 | -4.31% | 421,962 |
| 28/09/26 | $28.32 | +0.85% | 205,865 |
Sell
Buy

Mean consensus
BUY
Number of Analysts
4
Last Close Price
27.42USD
Average target price
62.25USD
Spread / Average Target
+127.02%
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- AVLN Stock
Select your edition
All financial news and data tailored to specific country editions

















